Literature DB >> 10559495

Expression of Frzb-1 during chick development.

D Duprez1, L Leyns, M A Bonnin, F Lapointe, H Etchevers, E M De Robertis, N Le Douarin.   

Abstract

We cloned the chick homolog of Xenopus and mouse Frzb-1, a secreted Wnt antagonist and performed in situ hybridizations to determine the pattern of cFrzb-1 expression in the developing chick embryo. At early stages, cFrzb-1 transcripts are located exclusively in the ectodermal layer corresponding to the neural plate. The labelling continues in the neural tube, but is always excluded from the floor plate. cFrzb-1 mRNA is expressed by migrating cephalic and truncal neural crest cells. Later, cFrzb-1 transcripts are found in a subset of neural crest derivatives such as cephalic cartilage, nerves and spinal ganglia. In addition to ectodermal derivatives, cFrzb-1 transcripts were also observed in mesodermal derivatives such as vertebral and limb cartilage, the adrenal cortex, the gonads, and a subpopulation of blood cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559495     DOI: 10.1016/s0925-4773(99)00206-3

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  11 in total

1.  Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation.

Authors:  Xizhi Guo; Timothy F Day; Xueyuan Jiang; Lisa Garrett-Beal; Lilia Topol; Yingzi Yang
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

2.  Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3.

Authors:  Lisa M Galli; Tiffany Barnes; Tina Cheng; Lisa Acosta; Adolph Anglade; Karl Willert; Roel Nusse; Laura W Burrus
Journal:  Dev Dyn       Date:  2006-03       Impact factor: 3.780

3.  Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata.

Authors:  Koshiro Nishimoto; Christine S Rigsby; Tao Wang; Kuniaki Mukai; Celso E Gomez-Sanchez; William E Rainey; Tsugio Seki
Journal:  Endocrinology       Date:  2012-02-28       Impact factor: 4.736

4.  Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.

Authors:  Julie C Baker-Lepain; John A Lynch; Neeta Parimi; Charles E McCulloch; Michael C Nevitt; Maripat Corr; Nancy E Lane
Journal:  Arthritis Rheum       Date:  2012-05

5.  The Wnt antagonists Frzb-1 and Crescent locally regulate basement membrane dissolution in the developing primary mouth.

Authors:  Amanda J G Dickinson; Hazel L Sive
Journal:  Development       Date:  2009-02-18       Impact factor: 6.868

6.  Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a.

Authors:  Zhongyan Zhang; Arjun Deb; Zhiping Zhang; Alok Pachori; Wei He; Jian Guo; Richard Pratt; Victor J Dzau
Journal:  J Mol Cell Cardiol       Date:  2008-12-09       Impact factor: 5.000

Review 7.  Wnt signaling in cartilage development and diseases: lessons from animal studies.

Authors:  Yu Usami; Aruni T Gunawardena; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

8.  Anteroposterior axis patterning by early canonical Wnt signaling during hemichordate development.

Authors:  Sébastien Darras; Jens H Fritzenwanker; Kevin R Uhlinger; Ellyn Farrelly; Ariel M Pani; Imogen A Hurley; Rachael P Norris; Michelle Osovitz; Mark Terasaki; Mike Wu; Jochanan Aronowicz; Marc Kirschner; John C Gerhart; Christopher J Lowe
Journal:  PLoS Biol       Date:  2018-01-16       Impact factor: 8.029

9.  Relationship between neural crest cells and cranial mesoderm during head muscle development.

Authors:  Julien Grenier; Marie-Aimée Teillet; Raphaëlle Grifone; Robert G Kelly; Delphine Duprez
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

Review 10.  The emerging roles of ribosome biogenesis in craniofacial development.

Authors:  Adam P Ross; Konstantinos S Zarbalis
Journal:  Front Physiol       Date:  2014-02-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.